Sequence
3145522 is from the genome.
The highlighted portions of sequence are where there is 75% agreement between all disorder pedictors.
>3145522
MEKLHQCYWKSGEPQSDDIEASRMKRAAAKHLIERYYHQLTEGCGNEACTNEFCASCPTFLRMDNNAAAIKALELYKINAKLCDPHPSKKGASSAYLENSKGAPNNSCSEIKMNKKGARIDFKDVTYLTEEKVYEILELCREREDYSPLIRVIGRVFSSAEALVQSFRKVKQHTKEELKSLQAKDEDKDEDEKEKAACSAAAMEEDSEASSSRIGDSSQGDNNLQKLGPDDVSVDIDAIRRVYTRLLSNEKIETAFLNALVYLSPNVECDLTYHNVYSRDPNYLNLFIIVMENRNLHSPEYLEMALPLFCKAMSKLPLAAQGKLIRLWSKYNADQIRRMMETFQQLITYKVISNEFNSRNLVNDDDAIVAASKCLKMVYYANVVGGEVDTNHNEEDDEEPIPESSELTLQELLGEERRNKKGPRVDPLETELGVKTLDCRKPLIPFEEFINEPLNEVLEMDKDYTFFKVETENKFSFMTCPFILNAVTKNLGLYYDNRIRMYSERRITVLYSLVQGQQLNPYLRLKVRRDHIIDDALVRLEMIAMENPADLKKQLYVEFEGEQGVDEGGVSKEFFQLVVEEIFNPDIGMFTYDESTKLFWFNPSSFETEGQFTLIGIVLGLAIYNNCILDVHFPMVVYRKLMGKKGTFRDLGDSHPVLYQSLKDLLEYEGNVEDDMMITFQISQTDLFGNPMMYDLKENGDKIPITNENRKEFVNLYSDYILNKSVEKQFKAFRRGFHMVTNESPLKYLFRPEEIELLICGSRNLDFQALEETTEYDGGYTRDSVLIREFWEIVHSFTDEQKRLFLQFTTGTDRAPVGGLGKLKMIIAKNGPDTERLPTSHTCFNVLLLPEYSSKEKLKERLLKAITYAKGFGML
View in source genome browser
UniProt Gene descriptions
UniProt |
Gene Name |
Gene Description |
G1QLH8 |
UBE3A |
Uncharacterized protein |
G3QMY2 |
UBE3A |
Uncharacterized protein |
H2Q918 |
ENSG00000114062 |
Uncharacterized protein |
Q05086 |
UBE3A |
Renal carcinoma antigen NY-REN-54 |
Disordered Regions
75% of predictor's agree:
Start |
End |
19 |
22 |
94 |
96 |
177 |
203 |
207 |
227 |
389 |
410 |
412 |
413 |
416 |
416 |
418 |
426 |
By predictor:
Predictor |
Start |
End |
VLXT |
1 |
2 |
VSL2b |
1 |
7 |
PrDOS |
1 |
28 |
PV2 |
1 |
33 |
IUPred-S |
1 |
9 |
Espritz-N |
1 |
6 |
Espritz-X |
1 |
5 |
VSL2b |
9 |
26 |
Espritz-N |
9 |
22 |
Espritz-X |
10 |
15 |
VLXT |
14 |
31 |
IUPred-L |
19 |
24 |
IUPred-S |
20 |
22 |
PrDOS |
55 |
128 |
VSL2b |
79 |
117 |
PV2 |
84 |
88 |
Espritz-N |
84 |
110 |
PV2 |
90 |
91 |
Espritz-X |
92 |
96 |
PV2 |
93 |
117 |
IUPred-S |
93 |
98 |
IUPred-L |
93 |
97 |
IUPred-L |
107 |
108 |
IUPred-S |
108 |
108 |
Espritz-N |
113 |
115 |
Espritz-N |
140 |
161 |
Espritz-X |
158 |
234 |
VSL2b |
164 |
230 |
PV2 |
167 |
236 |
PrDOS |
169 |
231 |
Espritz-N |
170 |
237 |
IUPred-L |
175 |
202 |
VLXT |
177 |
182 |
IUPred-S |
178 |
226 |
VLXT |
193 |
228 |
IUPred-L |
207 |
226 |
VLXT |
296 |
300 |
VSL2b |
298 |
299 |
VLXT |
324 |
332 |
Espritz-N |
384 |
404 |
PrDOS |
385 |
432 |
Espritz-X |
387 |
425 |
VSL2b |
388 |
448 |
PV2 |
388 |
448 |
VLXT |
389 |
453 |
IUPred-S |
389 |
425 |
IUPred-L |
389 |
410 |
IUPred-L |
412 |
413 |
Espritz-N |
415 |
427 |
IUPred-L |
416 |
416 |
IUPred-L |
418 |
427 |
PrDOS |
507 |
519 |
VLXT |
529 |
533 |
VLXT |
542 |
546 |
VSL2b |
561 |
569 |
Espritz-N |
562 |
569 |
PV2 |
565 |
567 |
VLXT |
568 |
575 |
PV2 |
609 |
609 |
PV2 |
616 |
618 |
PV2 |
628 |
628 |
VSL2b |
645 |
651 |
VSL2b |
698 |
698 |
Espritz-N |
699 |
702 |
VSL2b |
700 |
700 |
VSL2b |
702 |
704 |
PV2 |
702 |
704 |
VLXT |
748 |
753 |
VLXT |
762 |
767 |
VSL2b |
774 |
778 |
PV2 |
814 |
814 |
PV2 |
816 |
816 |
VLXT |
822 |
823 |
PV2 |
831 |
831 |
Espritz-N |
831 |
835 |
VSL2b |
833 |
836 |
PV2 |
833 |
836 |
PV2 |
838 |
843 |
PV2 |
849 |
850 |
VSL2b |
853 |
860 |
PV2 |
853 |
860 |
PrDOS |
870 |
873 |
VSL2b |
872 |
875 |
PV2 |
872 |
875 |
Espritz-N |
872 |
875 |
PrDOS |
874 |
875 |
IUPred-S |
874 |
875 |
SCOP Domain Regions
Hits with strong support:
Superfamily Name |
SFam ID |
SFam E-value |
Family Name |
Fam ID |
Fam E-value |
Region |
Hect, E3 ligase catalytic domain |
56204 |
1.44e-120 |
Hect, E3 ligase catalytic domain |
56205 |
0.00000000000219 |
521-868 |
Hits with weaker support:
No weak SCOP hits found.
Pfam Domain Regions
Type |
Clan |
Family |
Name |
Description |
E-value |
Bitscore |
Start |
End |
Pfam-B |
No Clan |
PB011726 |
|
|
0.000000000000001 |
58.2 |
54 |
119 |
Pfam-B |
No Clan |
PB004354 |
|
|
3.1e-64 |
214.7 |
361 |
482 |
Pfam-B |
No Clan |
PB018304 |
|
|
1.6e-19 |
71.1 |
442 |
575 |
Pfam-B |
No Clan |
PB019736 |
|
|
0.000000001 |
38.7 |
511 |
599 |
Pfam-B |
No Clan |
PB004838 |
|
|
0.0000018 |
27.6 |
552 |
593 |
Domain |
CL0552 |
PF00632.20 |
HECT |
HECT-domain (ubiquitin-transferase) |
1.6e-93 |
313.3 |
576 |
875 |
Post Translational Modification Sites
Locus |
Amino Acid |
Disordered |
PTM Type |
Sequence Context |
30 |
K |
Yes |
UBIQUITYLATION |
RMKRAAAkHLIERYY |
71 |
K |
Yes |
UBIQUITYLATION |
DNNAAAIkALELYkI |
77 |
K |
Yes |
UBIQUITYLATION |
IkALELYkINAKLCD |
90 |
K |
Yes |
UBIQUITYLATION |
CDPHPSKkGASSAyL |
96 |
Y |
Yes |
PHOSPHORYLATION |
KkGASSAyLENskGA |
100 |
S |
Yes |
PHOSPHORYLATION |
SSAyLENskGAPNNS |
101 |
K |
Yes |
UBIQUITYLATION |
SAyLENskGAPNNSC |
123 |
K |
Yes |
UBIQUITYLATION |
KGARIDFkDVTyLTE |
127 |
Y |
Yes |
PHOSPHORYLATION |
IDFkDVTyLTEEkVY |
132 |
K |
No |
UBIQUITYLATION |
VTyLTEEkVYEILEL |
158 |
S |
Yes |
PHOSPHORYLATION |
RVIGRVFssAEALVQ |
159 |
S |
Yes |
PHOSPHORYLATION |
VIGRVFssAEALVQS |
184 |
K |
Yes |
UBIQUITYLATION |
ELKSLQAkDEDKDED |
199 |
S |
Yes |
PHOSPHORYLATION |
EKEKAACsAAAMEED |
217 |
S |
Yes |
PHOSPHORYLATION |
SSSRIGDssQGDNNL |
218 |
S |
Yes |
PHOSPHORYLATION |
SSRIGDssQGDNNLQ |
226 |
K |
Yes |
UBIQUITYLATION |
QGDNNLQkLGPDDVS |
294 |
R |
No |
MONO-METHYLATION |
FIIVMENrNLHSPEY |
311 |
K |
No |
UBIQUITYLATION |
MALPLFCkAMSKLPL |
323 |
K |
No |
UBIQUITYLATION |
LPLAAQGkLIRLWSk |
330 |
K |
Yes |
UBIQUITYLATION |
kLIRLWSkYNADQIR |
342 |
T |
No |
PHOSPHORYLATION |
QIRRMMEtFQQLITy |
349 |
Y |
No |
PHOSPHORYLATION |
tFQQLITykVISNEF |
350 |
K |
No |
UBIQUITYLATION |
FQQLITykVISNEFN |
373 |
K |
No |
UBIQUITYLATION |
DAIVAASkCLKMVYY |
421 |
K |
Yes |
UBIQUITYLATION |
GEERRNKkGPRVDPL |
465 |
T |
No |
PHOSPHORYLATION |
LEMDKDYtFFkVEtE |
468 |
K |
No |
UBIQUITYLATION |
DKDYtFFkVEtENKF |
471 |
T |
No |
PHOSPHORYLATION |
YtFFkVEtENKFSFM |
479 |
T |
No |
PHOSPHORYLATION |
ENKFSFMtCPFILNA |
511 |
Y |
Yes |
PHOSPHORYLATION |
ERRITVLysLVQGQQ |
512 |
S |
Yes |
PHOSPHORYLATION |
RRITVLysLVQGQQL |
552 |
K |
No |
UBIQUITYLATION |
MENPADLkkQLYVEF |
553 |
K |
No |
UBIQUITYLATION |
ENPADLkkQLYVEFE |
711 |
K |
No |
UBIQUITYLATION |
PITNENRkEFVNLYS |
720 |
Y |
No |
PHOSPHORYLATION |
FVNLYSDyILNkSVE |
724 |
K |
No |
UBIQUITYLATION |
YSDyILNkSVEkQFK |
728 |
K |
No |
UBIQUITYLATION |
ILNkSVEkQFKAFRR |
802 |
K |
No |
UBIQUITYLATION |
HSFTDEQkRLFLQFT |
829 |
K |
Yes |
UBIQUITYLATION |
KLKMIIAkNGPDTER |
870 |
K |
Yes |
UBIQUITYLATION |
LKAITYAkGFGML__ |